If retatrutide is licensed in due course, switching can be considered then, on evidence rather than anticipation
Individuals recovering from acute illness benefit most from IV infusions for illness recovery
Site selection, rotation rules, and technique are the same
Clinical trials suggest tirzepatide might outperform semaglutide in certain aspects, though semaglutide has a more extensively documented safety and efficacy profile to date
Not for medical, therapeutic, or veterinary use
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial